Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550685071> ?p ?o ?g. }
- W2550685071 endingPage "12405" @default.
- W2550685071 startingPage "12389" @default.
- W2550685071 abstract "Bevacizumab (BV) is a humanized monoclonal antibody targeting vascular endothelial growth factor and it is the first molecular-targeted agent to be used for the treatment of ovarian cancer (OC). Randomized Phase III trials evaluated the combination of BV plus standard chemotherapy for first-line treatment of advanced OC and for platinum-sensitive and platinum-resistant recurrent OC. These trials reported a statistically significant improvement in progression-free survival but not in overall survival. Furthermore, BV effectively improved the quality of life with regard to abdominal symptoms in recurrent OC patients. Bevacizumab is associated with adverse events such as hypertension, bleeding, thromboembolism, proteinuria, delayed wound healing, and gastrointestinal events. However, most of these events can be adequately managed. This review describes the latest evidence for BV treatment of OC and selection of patients for personalized treatment." @default.
- W2550685071 created "2016-11-30" @default.
- W2550685071 creator A5010531543 @default.
- W2550685071 creator A5011813426 @default.
- W2550685071 creator A5015919378 @default.
- W2550685071 creator A5023782317 @default.
- W2550685071 creator A5039643755 @default.
- W2550685071 creator A5040375467 @default.
- W2550685071 creator A5051791738 @default.
- W2550685071 creator A5072059804 @default.
- W2550685071 creator A5076546888 @default.
- W2550685071 date "2016-11-11" @default.
- W2550685071 modified "2023-10-18" @default.
- W2550685071 title "Bevacizumab in ovarian cancer: A critical review of phase III studies" @default.
- W2550685071 cites W1603230122 @default.
- W2550685071 cites W1610065887 @default.
- W2550685071 cites W1793338775 @default.
- W2550685071 cites W1868125217 @default.
- W2550685071 cites W1894976735 @default.
- W2550685071 cites W1942713680 @default.
- W2550685071 cites W1966754084 @default.
- W2550685071 cites W1968741068 @default.
- W2550685071 cites W1974050413 @default.
- W2550685071 cites W1977093846 @default.
- W2550685071 cites W1991469761 @default.
- W2550685071 cites W2000763913 @default.
- W2550685071 cites W2002158391 @default.
- W2550685071 cites W2002710053 @default.
- W2550685071 cites W2006202974 @default.
- W2550685071 cites W2008051049 @default.
- W2550685071 cites W2012043034 @default.
- W2550685071 cites W2018929154 @default.
- W2550685071 cites W2021491702 @default.
- W2550685071 cites W2027988557 @default.
- W2550685071 cites W2028553713 @default.
- W2550685071 cites W2035146053 @default.
- W2550685071 cites W2040913401 @default.
- W2550685071 cites W2052066839 @default.
- W2550685071 cites W2060447671 @default.
- W2550685071 cites W2068854353 @default.
- W2550685071 cites W2076494316 @default.
- W2550685071 cites W2084740377 @default.
- W2550685071 cites W2087939757 @default.
- W2550685071 cites W2096235803 @default.
- W2550685071 cites W2096521047 @default.
- W2550685071 cites W2100785570 @default.
- W2550685071 cites W2102306754 @default.
- W2550685071 cites W2103563357 @default.
- W2550685071 cites W2104236657 @default.
- W2550685071 cites W2104326312 @default.
- W2550685071 cites W2105106087 @default.
- W2550685071 cites W2105556681 @default.
- W2550685071 cites W2105651363 @default.
- W2550685071 cites W2111242266 @default.
- W2550685071 cites W2113122060 @default.
- W2550685071 cites W2113182146 @default.
- W2550685071 cites W2113631881 @default.
- W2550685071 cites W2114159573 @default.
- W2550685071 cites W2116183806 @default.
- W2550685071 cites W2121604487 @default.
- W2550685071 cites W2121740300 @default.
- W2550685071 cites W2123113463 @default.
- W2550685071 cites W2125064537 @default.
- W2550685071 cites W2126275851 @default.
- W2550685071 cites W2130806638 @default.
- W2550685071 cites W2130941707 @default.
- W2550685071 cites W2131870939 @default.
- W2550685071 cites W2132611552 @default.
- W2550685071 cites W2134047636 @default.
- W2550685071 cites W2134961172 @default.
- W2550685071 cites W2135947389 @default.
- W2550685071 cites W2138035969 @default.
- W2550685071 cites W2147352361 @default.
- W2550685071 cites W2149117308 @default.
- W2550685071 cites W2149657444 @default.
- W2550685071 cites W2151050516 @default.
- W2550685071 cites W2154066587 @default.
- W2550685071 cites W2154885792 @default.
- W2550685071 cites W2154937126 @default.
- W2550685071 cites W2163012374 @default.
- W2550685071 cites W2167224460 @default.
- W2550685071 cites W2169965478 @default.
- W2550685071 cites W2170928115 @default.
- W2550685071 cites W2171234996 @default.
- W2550685071 cites W2171318838 @default.
- W2550685071 cites W2396783567 @default.
- W2550685071 cites W334278173 @default.
- W2550685071 doi "https://doi.org/10.18632/oncotarget.13310" @default.
- W2550685071 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5355353" @default.
- W2550685071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27852039" @default.
- W2550685071 hasPublicationYear "2016" @default.
- W2550685071 type Work @default.
- W2550685071 sameAs 2550685071 @default.
- W2550685071 citedByCount "85" @default.
- W2550685071 countsByYear W25506850712017 @default.
- W2550685071 countsByYear W25506850712018 @default.
- W2550685071 countsByYear W25506850712019 @default.
- W2550685071 countsByYear W25506850712020 @default.